共 14 条
- [1] Skogar O(2016)Pain management in patients with Parkinson’s disease: challenges and solutions J Multidiscip Healthc 9 469-479
- [2] Lokk J(2021)The long-term impact of levodopa/carbidopa intestinal gel on “off” time in patients with advanced Parkinson’s disease: a systematic review Adv Ther 38 2854-2890
- [3] Antonini A(2018)Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach Curr Med Res Opin 34 2063-2073
- [4] Odin P(2021)24-hour levodopa-carbidopa intestinal gel: clinical experience and practical recommendations CNS Drugs 35 137-149
- [5] Pahwa R(2020)Application of the “5-2-1” screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE Neurodegen Dis Manag 10 309-323
- [6] Antonini A(undefined)undefined undefined undefined undefined-undefined
- [7] Stoessl AJ(undefined)undefined undefined undefined undefined-undefined
- [8] Kleinman LS(undefined)undefined undefined undefined undefined-undefined
- [9] Thakkar S(undefined)undefined undefined undefined undefined-undefined
- [10] Fung VSC(undefined)undefined undefined undefined undefined-undefined